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Background: Accurate imaging of the aortic anatomy during Transcatheter Aortic
Valve Implantation (TAVI) is important as poor valve sizing may adversely affect
patient outcomes.
Methods: The aim of this study was to evaluate the feasibility of a using a large ﬁeld
intravascular ultrasound (IVUS) catheter (Visions PV0.35,Volcano corporation,San
Diego, CA) to guide valve sizing in TAVI. The catheter has a maximum imaging
diameter of 60 mm (as compared to <20 mm for coronary IVUS) and uses 10MHz
frequency ultrasound. The catheter is 8.5F sheath compatible and advanced in an
over-the-wire technique over a 0.35" wire.
Results: We performed aortic valve IVUS on 18 consecutive patients (mean age
813years, mean EuroSCOREII 16.6.08.5%, mean STS score 7.54.4%) for
planned transfemoral TAVI with the CoreValve (Medtronic, Minneapolis, MA). IVUS
imaging was performed pre-TAVI over a stiff 0.35" wire in the left ventricle. All 18
patients also had intra-procedure Trans-Oesophageal Echocardiography (TOE) and 16
of the 18 patients had pre-TAVI Multi-Detector Computed Tomography (MDCT) to
guide valve sizing. All patients had successful IVUS imaging with measurement of
minimum/maximum annulus diameters and annulus area/ perimeter. Of the patients
who had MDCT and IVUS, the annulus measurements were compared. The mean
annulus area was 398.8 80.2mm2 by IVUS and 390.463.7mm2 by MDCT while
the mean perimeter was 79.66.7mm by MDCT and 79.08.1mm by IVUS. There
was a positive correlation between the IVUS and MDCT annulus area and annulus
perimeter measurements (annulus area p¼0.19,r¼0.89,95%CI 0.72-0.95;annulus
perimeter p¼0.11, r¼0.91,CI 0.77-0.96) which was not statistically signiﬁcant. The
mean ellipticity index (EI) was greater when measured with IVUS (1.23) than when
measured with MDCT (1.21,p¼0.03). Also of interest was IVUS imaging post TAVI
which demonstrated valve leaﬂet function as well as frame expansion. There were no
procedural complications associated with the use of this technique.
Conclusions: Using IVUS to guide TAVI is feasible and warrants further evaluation
and comparison with other multi-modality imaging. The technique is fast, safe and
intuitive to operators with experience in coronary IVUS.
TCT-769
Impact of Elliptical Deployment and Under-Expansion at the Annulus on
Transcatheter Aortic Valve Performance: A Computational and Experimental
Investigation
Eric Sirois1, Kewei Li1, Joseph Calderan1, Susheel Kodali2, Wei Sun1
1University of Connecticut, Storrs, CT, 2Columbia, New York, United States
Background: Clinical use of transcatheter aortic valves (TAVs) has been associated
with abnormal deployment, including oval deployment and under-expansion when
placed into calciﬁed aortic annuli. In this study, we performed an integrated
computational and experimental investigation to quantify the impact of abnormal
deployment at the annulus on TAV hemodynamics.
Methods: A size 23 mm TAV computational model, developed and published
previously with key features similar to commercial valves, was subjected to elliptical
deployment at the annulus with eccentricity levels up to 0.68 and to under-expansion
of the TAV at the annulus by up to 15%. Hemodynamic performance parameters were
quantiﬁed for each TAV deployment conﬁguration. TAV opening geometries were
fabricated using additive manufacturing, and then subjected to steady forward ﬂow
testing in accordance with ISO-5840. Centerline pressure proﬁle and particle image
velocimetry analyses were performed to validate the computational models.
Results: Effective oriﬁce area (EOA) decreased with increased eccentricity, up to 17%
EOA reduction for eccentricity of 0.68. Under-expansion of the TAV at the annulus
signiﬁcantly reduced EOA by up to 33%. The combined effect of under-expansion
and ellipticity led to reductions in EOA greater than either effect individually, up to
41%. Peak velocity, turbulent kinetic energy (TKE) loss, and ﬂuid shear stress all
increased markedly with ellipticity and under-expansion (Table 1).
Conclusions: Elliptical deployment and under-expansion at the annulus can have
a signiﬁcant negative effect on TAV hemodynamics. Compared to full circular
deployment, TAVs that result in an elliptical shape and/or under-expansion at the
annulus demonstrated greatly decreased EOA. These results may have implications for
TAV design in favor of valves with complete and circular deployment at the annulus.
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before transcatheter aortic valve replacement (TAVR), although it is not riskless. Aims
of this work was to evaluate the feasibility and safety of TAVR with self-expandable
bioprosthesis performed without pre-dilatation of stenosed aortic valve.
Methods: We prospectively followed consecutive patients with symptomatic and
severe aortic stenosis undergoing TAVR with (group A) and without (group B) pre-
dilatation in our institution. The calciﬁcation of the device landing zone (DLZ) was
evaluated in all pts with a semiquantitative assessment by computed tomography
images. Primary end point was the feasibility of TAVR performed without pre-
dilatation. Secondary end point was a 30-day safety according to VARC-2 criteria.
Results: Between June 2011 and October 2012, 70 out of 80 consecutive pts were
included: 35 in group A and 35 in group B. Both groups had similar age (8110 vs
837 years old, respectively, p¼0.2), sex distribution (male 46% vs 43%, respec-
tively, p¼0.8), and DLZ-calciﬁcation score (grade 3-4: 71% vs 74%, respectively,
p¼0.07). Clinical risk proﬁle was higher in the second group (Log Euroscore I
2213% vs 3219%, respectively, p¼0.014). Devices success was similar (91% vs
97%, respectively, p¼0.3), as well as the incidence of post-dilatation (46% vs 37%,
respectively, p¼0.5) or second valve implanted (5.7% vs 2.8%, p¼0.5), irrespective of
valve size employed or DLZ-calciﬁcation score. The incidence of signiﬁcant para-
valvular leak post TAVI (2) is higher in pre-dilated group compared to no pre-
dilated one (17% vs 0%, respectively, p¼0.01), even if it was not emodinamically
relevant (AR index 32.7 vs 33.9, respectively, p¼0.46). No signiﬁcant difference in
all-cause death were observed (14% vs 6%, respectively, p¼0.24). No cerebrovascular
events occurred. Both groups had similar incidence of PM implantation post TAVI
(26% in both groups).
Conclusions: TAVI with self-expandable bioprosthesis without balloon pre-dilatation
is feasible and safe. Further study are warranted in order to evaluate the impact on
silent cerebral embolic lesion and procedural costs.
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Background: In patients with enlarged left ventricles the detection of left bundle
branch block (LBBB) can be ambiguous using ECG criteria. The left ventricle is
frequently remodeled in patients with aortic valve stenosis. Replacing the aortic valve
during a TAVI procedure often induces BBBs, most likely related to the mechanical
interaction of the implanted valve and the conduction system. The objective of this
feasibility study was to differentiate between various types of intra-ventricular
conduction disorders by using the activation based ECG Imaging (ECGI) method.
Methods: The activation based ECGI method requires a patient speciﬁc model of the
heart and thorax, which are derived from computed tomography data by a dedicated
morphing computer software tool. From 10 TAVI patients 20 representative 12 lead
ECG beats recorded pre- and post-implantation were used to create ventricular acti-
vation isochrones. These isochrones visualize the ventricular depolarization sequence.
Results: The activation isochrones were visually analyzed and compared to the
diagnoses from standard 12 lead ECG. Fourteen estimated activation isochrones were
in accordance with the ECG criteria: 3 beats could be correctly identiﬁed as RBBB, 9
beats as LBBB, and 2 beats as normal activations. For the remaining 6 beats the
isochrones showed partial block patterns.Conclusions: This activation based ECGI method is able to visualize intra-ventricular
conduction disorders. The method could be helpful understanding electrical activation
changes in TAVI patients and to help optimizing further treatment.1, 2013 j TCT Abstracts/POSTER/Aortic Valve Disease and Treatment
